Inhibition of BRN2 in Melanoma Reverses Anoikis Resistance and Sensitizes Cells to Killing by Vemurafenib
Hannah M. Neuendorf, Xie He, Mark N. Adams, Sharon Chow, Khoa Anh Tran, Aaron G. Smith, Paul V. Bernhardt, Craig M. Williams, Jacinta L. Simmons, Glen M. Boyle
This paper shows that inhibiting BRN2 in melanoma cells reverses anoikis resistance and increases sensitivity to Vemurafenib.
Journal of Experimental & Clinical Cancer Research · Sep 5, 2026Peer-reviewedCancer Biology